Corrigendum to “Tumor-derived KLK5 activates TMEM158+ cancer-associated fibroblasts to induce CD8+ T cell exhaustion and confer resistance to cancer immunotherapy” [Drug Resist. Updates, Vol. 90, January 2027, 101473]
Year: 2026
Type: erratum
Source: Drug Resistance Updates
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7220396357
